[Federal Register Volume 78, Number 191 (Wednesday, October 2, 2013)]
[Notices]
[Pages 60886-60887]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2013-23972]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Submission for OMB Review; 30-day Comment Request; Quantification 
of Behavioral and Physiological Effects of Drugs Using a Mobile 
Scalable Device

SUMMARY: Under the provisions of Section 3507(a)(1)(D) of the Paperwork 
Reduction Act of 1995, the National Institute on Drug Abuse (NIDA), the 
National Institutes of Health (NIH) has submitted to the Office of 
Management and Budget (OMB) a request for review and approval of the 
information collection listed below. This proposed information 
collection was previously published in the Federal Register on March 
29, 2013, Vol.78, No.61, pages 19273-19274, and allowed 60-days for 
public comment. No public comments were received. The purpose of this 
notice is to allow an additional 30 days for public comment. The 
National Institute on Drug Abuse (NIDA), the National Institutes of 
Health, may not conduct or sponsor, and the respondent is not required 
to respond to, an information collection that has been extended, 
revised, or implemented on or after October 1, 1995, unless it displays 
a currently valid OMB control number.
    Direct Comments to OMB: Written comments and/or suggestions 
regarding the item(s) contained in this notice, especially regarding 
the estimated public burden and associated response time, should be 
directed to the: Office of Management and Budget, Office of Regulatory 
Affairs, [email protected] or by fax to 202-395-6974, 
Attention: NIH Desk Officer.

DATES: Comments Due Date: Comments regarding this information 
collection are best assured of having their full effect if received 
within 30-days of the date of this publication.

FOR FURTHER INFORMATION CONTACT: To obtain a copy of the data 
collection plans and instruments, submit comments in writing, or 
request more information on the proposed project contact: Dr. Steve 
Gust, National Institute on Drug Abuse, 6001 Executive Blvd., Bethesda, 
MD 20892, or call non-toll-free number (301) 443-6480 or Email your 
request, including your address to: [email protected]. Formal requests 
for additional plans and instruments must be requested in writing.
    Proposed Collection: Quantification of Behavioral and Physiological 
Effects of Drugs Using a Mobile Scalable Device, 0925-New, National 
Institute on Drug Abuse (NIDA), National Institutes of Health (NIH).
    Need and Use of Information Collection: This study will examine the 
effectiveness of a mobile scalable device to detect the impairing 
effects of different drugs. The primary purpose of the data collected 
is to determine eligibility in a driving simulation study and to verify 
the effectiveness of the experimental manipulations. The findings will 
provide valuable information concerning the utility and effectiveness 
of mobile, smartphone/tablet-based neurocognitive assessment that can 
provide a multifactorial evaluation of cognitive functioning associated 
with impaired driving.
    OMB approval is requested for 18 months. There are no costs to 
respondents other than their time. The total estimated annualized 
burden hours are 859.

                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                     Number of    Average burden
           Form name                 Type of         Number of     responses per   per response     Per annual
                                   respondent       respondents     respondent      (in hours)      hour burden
----------------------------------------------------------------------------------------------------------------
Phone Screening...............  Adults..........             100               1           10/60              17
Consent Process, In-Person      Adults..........  ..............  ..............           45/60              75
 Screening Adderall.
Consent Process, In-Person      Adults..........             100  ..............           45/60              75
 Screening Xanax.
Consent Process, In-Person      Adults..........  ..............  ..............           45/60              75
 Screening Cannabis.
Driving Survey................  Adults..........  ..............               1           15/60              18
Realism Survey................  Adults..........  ..............               1            3/60               4
Sleep and Intake Questionnaire  Adults..........  ..............               2            3/60               7
Stanford Sleepiness Scale.....  Adults..........              72               6            1/60               7
Wellness Survey...............  Adults..........  ..............               2            2/60               5
Dosing/Driving/Waiting........  Adults..........  ..............               2               4             576
----------------------------------------------------------------------------------------------------------------



[[Page 60887]]

    Dated: September 25, 2013.
Glenda J. Conroy,
Executive Officer (OM Director), NIDA, NIH.
[FR Doc. 2013-23972 Filed 10-1-13; 8:45 am]
BILLING CODE 4140-01-P